Results (3739)

Review of medicines containing finasteride and dutasteride concluded
Suicidal thoughts confirmed as side effect of finasteride tablets; no direct link found for dutasteride

EU regulators agree workplan to optimise use of data and artificial intelligence (AI)
Vaccine must not be used in people 65 years and above while review is underway
The European Medicines Agency's (EMA) office is closed from 18:00 on 8 May 2025 to 08:30 on 12 May 2025
The European Medicines Agency's (EMA) office is closed from 18:00 on 30 April 2025 to 08:30 on 2 May 2025
Consultation of the Board constitutes first step of renewal process

16 new medicines recommended for approval; another ten medicines recommended for extension of their therapeutic indications
Duvyzat can be used in a wide patient population from the age of six
Tepezza significantly improves symptoms for patients with moderate-to-severe TED